Importer of Controlled Substances; Notice of Application, 48779-48780 [05-16467]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 160 / Friday, August 19, 2005 / Notices
The Commission will transmit its
determination in this investigation to
the Secretary of Commerce on August
15, 2004. The views of the Commission
are contained in USITC Publication
3792 (August 2005), entitled Metal
Calendar Slides from Japan:
Investigation No. 731–TA–1094
(Preliminary).
Dated: August 11, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–16468 Filed 8–18–05; 8:45 am]
By order of the Commission.
Issued: August 15, 2005.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 05–16425 Filed 8–18–05; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on March 16,
2005, Abbott Laboratories, DBA Knoll
Pharmaceutical Company, 30 North
Jefferson Road, Whippany, New Jersey
07981, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
Schedules I and II:
Drug
Schedule
Dihydromorphine (9145) ...............
Hydromorphone (9150) ................
I
II
The company plans to manufacture
bulk product and dosage units for
distribution to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than October 18, 2005.
VerDate jul<14>2003
16:47 Aug 18, 2005
Jkt 205001
Pursuant to section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on March 7,
2005, Lonza Riverside, 900 River Road,
Conshohocken, Pennsylvania 19428,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
Schedules I and II:
Drug
Schedule
Gamma
hydroxybutyric
acid
(2010).
Amphetamine (1100) ....................
Methylphenidate (1724) ................
I
II
II
The company plans to manufacture
bulk products for finished dosage units
and distribution to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than October 18, 2005.
Dated: August 11, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–16469 Filed 8–18–05; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00117
Fmt 4703
Sfmt 4703
48779
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated March 29, 2005, and
published in the Federal Register on
April 6, 2005, (70 FR 17473), Polaroid
Corporation, 1265 Main Street, Building
W6, Waltham, Massachusetts 02454,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of 2,5Dimethoxyamphetamine (7396), a basic
class of controlled substance listed in
Schedule I.
The company plans to manufacture
the listed controlled substance in bulk
for conversion into non-controlled
substances.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Polaroid Corporation to manufacture the
listed basic class of controlled substance
is consistent with the public interest at
this time. DEA has investigated Polaroid
Corporation to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
Dated: August 12, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–16466 Filed 8–18–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this section to a
bulk manufacturer of a controlled
substance in Schedule I or II and prior
to issuing a regulation under 21 U.S.C.
952(a)(2)(B) authorizing the importation
of such a substance, provide
E:\FR\FM\19AUN1.SGM
19AUN1
48780
Federal Register / Vol. 70, No. 160 / Friday, August 19, 2005 / Notices
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on April
8, 2005, Research Triangle Institute,
Kenneth H. Davis Jr., Hermann Building
East Institute Drive, P.O. Box 12194,
Research Triangle Park, North Carolina
27709, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
the basic class of controlled substance
listed in Schedule II:
Drug
Schedule
Cocaine (9041) .............................
II
The company plans to import small
quantities of the listed controlled
substance for the National Institute of
Drug Abuse and other clients.
Any manufacturer who is presently,
or is applying to be, registered with DEA
to manufacture such basic classes of
controlled substances may file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than September 19, 2005.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance listed in
Schedule I or II are, and will continue
to be required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 1301.34(b), (c),(d),(e) and (f) are
satisfied.
VerDate jul<14>2003
16:47 Aug 18, 2005
Jkt 205001
Dated: August 11, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–16467 Filed 8–18–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on January 26,
2005, Sigma Aldrich Research,
Biochemicals, Inc., 1–3 Strathmore
Road, Natick, Massachusetts 01760,
made application by letter to the Drug
Enforcement Administration (DEA) for
registration as a bulk manufacturer of NBenzylpiperazine (7493), a basic class of
controlled substance listed in Schedule
I.
The company plans to manufacture
the listed controlled substance in bulk
for distribution to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than October 18, 2005.
Dated: August 12, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–16465 Filed 8–18–05; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00118
Fmt 4703
Sfmt 4703
DEPARTMENT OF LABOR
Employment and Training
Administration
Proposed Information Collection
Request Submitted for Public
Comment and Recommendations;
Labor Certification for the Temporary
Employment of Nonimmigrant Aliens
in Agriculture in the United States;
Administrative Measures To Improve
Program Performance
ACTION:
Notice.
SUMMARY: The Department of Labor, as
part of its continuing effort to reduce
paperwork and respondent burden,
conducts a preclearance consultation
program to provide the general public
and Federal agencies with an
opportunity to comment on proposed
and/or continuing collections of
information in accordance with the
Paperwork Reduction Act of 1995
(PRA95) (44 U.S.C. 3506(c)(A)). This
program helps to ensure that requested
data can be provided in the desired
format, reporting burden (time and
financial resources) is minimized,
collection instruments are clearly
understood, and the impact of collection
requirements on respondents can be
properly assessed. Currently, the
Employment and Training
Administration, Office of National
Programs, is soliciting comments
concerning the proposed extension of
the collection for the Labor Certification
for the Temporary Employment of
Nonimmigrant Aliens in Agriculture in
the Unites States; Administrative
Measures to Improve Program
Performance. A copy of the proposed
Information Collection Request (ICR)
can be obtained by contacting the office
listed below in the addressee section of
this notice.
DATES: Written comments must be
submitted to the office listed in the
addressee’s section below on or before
October 18, 2005.
ADDRESSES: John R. Beverly,
Administrator, Office of National
Programs, U.S. Department of Labor,
Employment and Training
Administration, Room C–4312, 200
Constitution Avenue, NW., Washington,
DC 20210, phone: (202) 693–3010 (this
is not a toll-free number); Fax: (202)
693–2768; e-mail:
ETAperforms@dol.gov.
FOR FURTHER INFORMATION CONTACT:
Gregory Wilson, Program Analyst,
Division of Foreign Labor Certification,
U.S. Department of Labor, Employment
& Training Administration, Room C–
4312, 200 Constitution Avenue, NW.,
E:\FR\FM\19AUN1.SGM
19AUN1
]]>Agencies
[Federal Register Volume 70, Number 160 (Friday, August 19, 2005)]
[Notices]
[Pages 48779-48780]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-16467]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to
issuing a registration under this section to a bulk manufacturer of a
controlled substance in Schedule I or II and prior to issuing a
regulation under 21 U.S.C. 952(a)(2)(B) authorizing the importation of
such a substance, provide
[[Page 48780]]
manufacturers holding registrations for the bulk manufacture of the
substance an opportunity for a hearing.
Therefore, in accordance with 21 CFR 1301.34(a), this is notice
that on April 8, 2005, Research Triangle Institute, Kenneth H. Davis
Jr., Hermann Building East Institute Drive, P.O. Box 12194, Research
Triangle Park, North Carolina 27709, made application by renewal to the
Drug Enforcement Administration (DEA) to be registered as an importer
of the basic class of controlled substance listed in Schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cocaine (9041)............................. II
------------------------------------------------------------------------
The company plans to import small quantities of the listed
controlled substance for the National Institute of Drug Abuse and other
clients.
Any manufacturer who is presently, or is applying to be, registered
with DEA to manufacture such basic classes of controlled substances may
file comments or objections to the issuance of the proposed
registration and may, at the same time, file a written request for a
hearing on such application pursuant to 21 CFR 1301.43 and in such form
as prescribed by 21 CFR 1316.47.
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than September 19, 2005.
This procedure is to be conducted simultaneously with and
independent of the procedures described in 21 CFR 1301.34(b), (c), (d),
(e) and (f). As noted in a previous notice published in the Federal
Register on September 23, 1975, (40 FR 43745-46), all applicants for
registration to import a basic class of any controlled substance listed
in Schedule I or II are, and will continue to be required to
demonstrate to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and
21 CFR 1301.34(b), (c),(d),(e) and (f) are satisfied.
Dated: August 11, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-16467 Filed 8-18-05; 8:45 am]
BILLING CODE 4410-09-P
